Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-gs4-03
Abstract: Background: The Clinical Treatment Score at 5 years (CTS5) is a prognostic tool using clinicopathological parameters (nodal status, tumor size, grade, and age) to estimate distant recurrence (DR) risk after 5 years of endocrine treatment…
read more here.
Keywords:
positive her2;
treatment;
tailorx study;
cts5 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.514
Abstract: 514 Background: The Clinical Treatment Score at 5 years (CTS5) is a prognostic tool using clinicopathological data to estimate distant recurrence (DR) risk after 5 years of endocrine therapy for postmenopausal women with estrogen receptor…
read more here.
Keywords:
risk late;
unselected non;
risk;
cohort ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.555
Abstract: 555 Background: Identification of N+ breast cancer patients with a limited risk of recurrence improves selection of those for which chemotherapy and/or extended endocrine therapy (EET) may be most appropriate to reduce overtreatment. BCIN+ integrates…
read more here.
Keywords:
breast cancer;
risk late;
cts5;
risk ... See more keywords